Tepezza Pricing in 2025: Discounts and Additional Deals
In the realm of healthcare, understanding the cost of treatments can be a complex matter. This is particularly true for specialty biologics like Tepezza (teprotumumab-trbw), a drug used to treat thyroid eye disease (TED) in adults.
The average cost of Tepezza without insurance can be roughly $14,900 per infusion, with patients typically requiring several infusions (usually 8 doses), leading to a total treatment cost around $119,000 to $120,000. However, with insurance coverage, the out-of-pocket costs vary widely depending on the patient's insurance plan, copays, deductibles, and patient assistance programs offered by manufacturers or insurers.
Several factors influence the price of Tepezza. Insurance coverage plays a significant role, as whether the drug is covered by a patient's insurance plan and the extent of coverage (copay, coinsurance, deductibles) can greatly impact the cost. The treatment plan and dose frequency are also crucial, as patients typically receive 8 infusions, and the total cost depends on how many doses are needed.
Other factors include pharmacy and healthcare provider fees, geographic location and healthcare provider, manufacturer pricing and competition, patient assistance programs, and legal and litigation factors. For instance, ongoing lawsuits related to side effects may eventually influence costs or coverage if settlements or regulatory actions arise.
Amgen, the manufacturer of Tepezza, has reported increased sales revenues for Tepezza, suggesting ongoing pricing stability or adjustments influenced by market demand and regulatory approvals, including recent European approval in 2025. However, specific average insured cost data is not detailed in the available search results.
For those seeking to learn about the cost of Tepezza and what copay assistance is available, Amgen offers a support program called Amgen By Your Side. You can contact them at 833-483-7399 or visit their program website for more information. Additionally, websites such as Medicine Assistance Tool and NeedyMeds provide details about drug assistance programs, ways to make the most of insurance coverage, and links to savings cards and other services.
It's essential to remember that this drug information is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. Always consult your doctor or another healthcare professional before taking any medication.
For more information about eye health, visit our eye health hub.
[1] Amgen Q2 2025 Earnings Report [2] Tepezza Prescribing Information [3] Pharmaceutical Pricing Survey 2025
- The high cost of Tepezza, a drug used to treat thyroid eye disease, is influenced by various factors such as insurance coverage, treatment plans, healthcare provider fees, manufacturing pricing, location, legal factors, and patient assistance programs.
- With insurance, out-of-pocket costs for Tepezza vary significantly based on the patient's insurance plan, copays, deductibles, and potential assistance programs offered by manufacturers or insurers.
- For patients seeking assistance with Tepezza costs, resource options include Amgen's support program called Amgen By Your Side, along with websites like Medicine Assistance Tool and NeedyMeds, which offer details about drug assistance programs, insurance coverage tips, and savings opportunities.
